Current Neuropharmacology


Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 14 Issue: 2, February 2016

Meet Our Editorial Board Member: free to download

Volume:14   Issue: 2
Pp: 117-117
Massimo Avoli
DOI: 10.2174/1570159X1402160215180602
Published on: 15 February, 2016

Mitochondrial Biology and Neurological Diseases

Volume:14   Issue: 2
Pp: 143-154
Siddharth Arun, Lei Liu and Gizem Donmez
DOI: 10.2174/1570159X13666150703154541
Published on: 03 July, 2015

LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals

Volume:14   Issue: 2
Pp: 155-164
Miryam Nava Catorce and Goar Gevorkian
DOI: 10.2174/1570159X14666151204122017
Published on: 04 December, 2015

Kappa Opioids, Salvinorin A and Major Depressive Disorder

Volume:14   Issue: 2
Pp: 165-176
George T. Taylor and Francesca Manzella
DOI: 10.2174/1570159X13666150727220944
Published on: 27 July, 2015

Alzheimer’s Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome

Volume:14   Issue: 2
Pp: 177-190
A. Giulietti, A. Vignini, L. Nanetti, L. Mazzanti, R. Di Primio and E. Salvolini
DOI: 10.2174/1570159X13666150928155321
Published on: 28 September, 2015

The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review

Volume:14   Issue: 2
Pp: 191-199
Antonio Bruno, Paolo Morabito, Edoardo Spina and Maria Rosaria Muscatello
DOI: 10.2174/1570159X14666151117122458
Published on: 17 November, 2015

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects

Volume:14   Issue: 2
Pp: 200-209
Zsófia Majláth, Nóra Török, József Toldi and László Vécsei
DOI: 10.2174/1570159X14666151113123221
Published on: 13 November, 2015